Inducing All Our ‘Low-Risk’ Transplant Candidates: Shall We Or Shall We Not?
Journal Title: Journal of Urology & Nephrology - Year 2017, Vol 4, Issue 1
Abstract
Acute rejection episode (ARE) in an allograft recipient has a negative impact on graft survival, and therefore, preventing ARE is of paramount importance. Induction by antibody preparations is one such strategy that has been proven effective in preventing AREs, but there are certain ambiguities in their use particularly in low immunological risk transplants. Anti-interleukin-2 receptor therapy had gained widespread usage in this group of patients because it does not incur additional risks of infectious and malignant sequelae associated with thymoglobulin. However, recent literature found it to be no better than “no induction” strategy. Thymoglobulin, being frequently used in North America for induction even in low risk group, has been used in variable doses across transplant centers. The minimal possible dose of Thymoglobulin that avoids majority of adverse effects while retaining an optimal treatment benefit has not been clearly defined. Moreover, the effects of induction by antibody preparations on long term graft function and survival remain variable. Majority of the published work on induction immunosuppression is retrospective and is difficult to interpret because of a wide spectrum of maintenance immunosuppressive regimen in vogue. This review of literature has been performed to analyse published literature to assess the efficacy and appropriateness of induction agents in “low risk” transplants. We suggest that ‘low-risk patients receiving triple-drug immunosuppression(calcineurin inhibitors, an anti-proliferative agent and steroids) do not need ‘routine’ induction by antibody preparations.
Authors and Affiliations
Ahmed Halawa
Keywords
Related Articles
- EP ID EP207455
- DOI 10.13188/2380-0585
- Views 134
- Downloads 0
Early Surgical Correction of Ureteropelvic Junction Obstruction
Based on the analysis of 131 (from month 1 to 3 years old) children with Ureteropelvic Junction (UPJ) obstruction, who underwent early pyeloplasty, it was found that the incidence of intra and postoperative complications...
Testicular Epidermoid Cyst: Case Report and Literature Review
Introduction: Testicular epidermoid cysts are extremely uncommon. They are considered as benign tumors. Although an inguinal orchiectomy is the standard procedure for testicular tumors, if the presence of an epidermoid c...
Future Applications of Intravesical SCL Gene Transfer for the Treatment of Diabetic Neurogenic Bladder
Diabetic cystopathy, a complication of diabetes affecting the bladder, is mainly characterized as reduced contractility of the detrusor and increased post-voiding residual volume, which is induced by the reduction of the...
Bid Cleavage and TRAIL Sensitivity in Urothelial Cell Carcinoma of the Bladder
opensity to recur after resection. Intravesical bacillus calmetteguerin (BCG) therapy significantly reduces recurrence of UCCB, and response to BCG therapy is believed to be mediated by tumor necrosis factor related apop...
Handgrip Strength and Weight Predict Long-Term Mortality in Acute Kidney Injury Patients
Introduction: Surviving acute kidney (AKI) patients have a higher late mortality. The negative impact of malnutrition on the early outcome of AKI patients has recently been confirmed by various studies. However, its impa...